The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas: a scoping review

Patricia Fox, Andrew Darley, Eileen Furlong, Christine Miaskowski, Elisabeth Patiraki, Jo Armes, Emma Ream, Constantina Papadopoulou, Lisa McCann, Nora Kearney, Roma Maguire

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

PURPOSE: The purpose of the eSMART (Electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology) study is to evaluate the use of mobile phone technology to manage chemotherapy-related toxicities (CRTs) in people with breast cancer (BC), colorectal cancer (CRC), Hodgkin's lymphoma (HL), and non-Hodgkin lymphoma (NHL)) across multiple European sites. One key objective was to review the published and grey literature on assessment and management of CRTs among patients receiving primary chemotherapy for BC, CRC, HL, and NHL to ensure that ASyMS remained evidence-based and reflected current and local practice.

METHODS: Three electronic databases were searched for English papers, with abstracts available from 01/01/2004-05/04/2014. For the grey literature, relevant clinical practice guidelines (CPGs)/evidence-based resources (EBRs) from the main international cancer organisations were reviewed as were symptom management (SM) protocols from the sites.

RESULTS: After full-text screening, 27 publications were included. The majority (n = 14) addressed fatigue and focused on BC patients. Relevant CPGs/EBRs were found for fatigue (n = 4), nausea/vomiting (n = 5), mucositis (n = 4), peripheral neuropathy (n = 3), diarrhoea (n = 2), constipation (n = 2), febrile neutropenia/infection (n = 7), palmar plantar erythrodysesthesia (PPE) (n = 1), and pain (n = 4). SM protocols were provided by >40% of the clinical sites.

CONCLUSIONS: A need exists for empirical research on SM for PPE, diarrhoea, and constipation. Research is needed on the efficacy of self-care strategies in patients with BC, CRC, HL, and NHL. In general, consistency exists across CPGs/EBRs and local guidelines on the assessment and management of common CRTs.

LanguageEnglish
Pages63-82
Number of pages20
JournalEuropean Journal of Oncology Nursing
Volume26
Early online date22 Dec 2016
DOIs
Publication statusPublished - 28 Feb 2017

Fingerprint

Hodgkin Disease
Non-Hodgkin's Lymphoma
Colorectal Neoplasms
Practice Guidelines
Breast Neoplasms
Literature
Drug Therapy
Constipation
Fatigue
Diarrhea
Technology
Febrile Neutropenia
Mucositis
Cell Phones
Empirical Research
Peripheral Nervous System Diseases
Self Care
Nausea
Vomiting
Publications

Keywords

  • adult
  • aged
  • aged, 80 and over
  • antineoplastic agents
  • breast neoplasms
  • cell phones
  • colorectal neoplasms
  • drug therapy
  • drug-related side effects
  • Europe
  • female
  • Hodgkin disease
  • humans
  • lymphoma

Cite this

Fox, Patricia ; Darley, Andrew ; Furlong, Eileen ; Miaskowski, Christine ; Patiraki, Elisabeth ; Armes, Jo ; Ream, Emma ; Papadopoulou, Constantina ; McCann, Lisa ; Kearney, Nora ; Maguire, Roma. / The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas : a scoping review. In: European Journal of Oncology Nursing. 2017 ; Vol. 26. pp. 63-82.
@article{066f79b850114499a849ae732ec3496a,
title = "The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas: a scoping review",
abstract = "PURPOSE: The purpose of the eSMART (Electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology) study is to evaluate the use of mobile phone technology to manage chemotherapy-related toxicities (CRTs) in people with breast cancer (BC), colorectal cancer (CRC), Hodgkin's lymphoma (HL), and non-Hodgkin lymphoma (NHL)) across multiple European sites. One key objective was to review the published and grey literature on assessment and management of CRTs among patients receiving primary chemotherapy for BC, CRC, HL, and NHL to ensure that ASyMS remained evidence-based and reflected current and local practice.METHODS: Three electronic databases were searched for English papers, with abstracts available from 01/01/2004-05/04/2014. For the grey literature, relevant clinical practice guidelines (CPGs)/evidence-based resources (EBRs) from the main international cancer organisations were reviewed as were symptom management (SM) protocols from the sites.RESULTS: After full-text screening, 27 publications were included. The majority (n = 14) addressed fatigue and focused on BC patients. Relevant CPGs/EBRs were found for fatigue (n = 4), nausea/vomiting (n = 5), mucositis (n = 4), peripheral neuropathy (n = 3), diarrhoea (n = 2), constipation (n = 2), febrile neutropenia/infection (n = 7), palmar plantar erythrodysesthesia (PPE) (n = 1), and pain (n = 4). SM protocols were provided by >40{\%} of the clinical sites.CONCLUSIONS: A need exists for empirical research on SM for PPE, diarrhoea, and constipation. Research is needed on the efficacy of self-care strategies in patients with BC, CRC, HL, and NHL. In general, consistency exists across CPGs/EBRs and local guidelines on the assessment and management of common CRTs.",
keywords = "adult, aged, aged, 80 and over, antineoplastic agents, breast neoplasms, cell phones, colorectal neoplasms, drug therapy, drug-related side effects, Europe, female, Hodgkin disease, humans, lymphoma",
author = "Patricia Fox and Andrew Darley and Eileen Furlong and Christine Miaskowski and Elisabeth Patiraki and Jo Armes and Emma Ream and Constantina Papadopoulou and Lisa McCann and Nora Kearney and Roma Maguire",
note = "Copyright {\circledC} 2016 Elsevier Ltd. All rights reserved.",
year = "2017",
month = "2",
day = "28",
doi = "10.1016/j.ejon.2016.12.008",
language = "English",
volume = "26",
pages = "63--82",
journal = "European Journal of Oncology Nursing",
issn = "1462-3889",

}

The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas : a scoping review. / Fox, Patricia; Darley, Andrew; Furlong, Eileen; Miaskowski, Christine; Patiraki, Elisabeth; Armes, Jo; Ream, Emma; Papadopoulou, Constantina; McCann, Lisa; Kearney, Nora; Maguire, Roma.

In: European Journal of Oncology Nursing, Vol. 26, 28.02.2017, p. 63-82.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas

T2 - European Journal of Oncology Nursing

AU - Fox, Patricia

AU - Darley, Andrew

AU - Furlong, Eileen

AU - Miaskowski, Christine

AU - Patiraki, Elisabeth

AU - Armes, Jo

AU - Ream, Emma

AU - Papadopoulou, Constantina

AU - McCann, Lisa

AU - Kearney, Nora

AU - Maguire, Roma

N1 - Copyright © 2016 Elsevier Ltd. All rights reserved.

PY - 2017/2/28

Y1 - 2017/2/28

N2 - PURPOSE: The purpose of the eSMART (Electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology) study is to evaluate the use of mobile phone technology to manage chemotherapy-related toxicities (CRTs) in people with breast cancer (BC), colorectal cancer (CRC), Hodgkin's lymphoma (HL), and non-Hodgkin lymphoma (NHL)) across multiple European sites. One key objective was to review the published and grey literature on assessment and management of CRTs among patients receiving primary chemotherapy for BC, CRC, HL, and NHL to ensure that ASyMS remained evidence-based and reflected current and local practice.METHODS: Three electronic databases were searched for English papers, with abstracts available from 01/01/2004-05/04/2014. For the grey literature, relevant clinical practice guidelines (CPGs)/evidence-based resources (EBRs) from the main international cancer organisations were reviewed as were symptom management (SM) protocols from the sites.RESULTS: After full-text screening, 27 publications were included. The majority (n = 14) addressed fatigue and focused on BC patients. Relevant CPGs/EBRs were found for fatigue (n = 4), nausea/vomiting (n = 5), mucositis (n = 4), peripheral neuropathy (n = 3), diarrhoea (n = 2), constipation (n = 2), febrile neutropenia/infection (n = 7), palmar plantar erythrodysesthesia (PPE) (n = 1), and pain (n = 4). SM protocols were provided by >40% of the clinical sites.CONCLUSIONS: A need exists for empirical research on SM for PPE, diarrhoea, and constipation. Research is needed on the efficacy of self-care strategies in patients with BC, CRC, HL, and NHL. In general, consistency exists across CPGs/EBRs and local guidelines on the assessment and management of common CRTs.

AB - PURPOSE: The purpose of the eSMART (Electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology) study is to evaluate the use of mobile phone technology to manage chemotherapy-related toxicities (CRTs) in people with breast cancer (BC), colorectal cancer (CRC), Hodgkin's lymphoma (HL), and non-Hodgkin lymphoma (NHL)) across multiple European sites. One key objective was to review the published and grey literature on assessment and management of CRTs among patients receiving primary chemotherapy for BC, CRC, HL, and NHL to ensure that ASyMS remained evidence-based and reflected current and local practice.METHODS: Three electronic databases were searched for English papers, with abstracts available from 01/01/2004-05/04/2014. For the grey literature, relevant clinical practice guidelines (CPGs)/evidence-based resources (EBRs) from the main international cancer organisations were reviewed as were symptom management (SM) protocols from the sites.RESULTS: After full-text screening, 27 publications were included. The majority (n = 14) addressed fatigue and focused on BC patients. Relevant CPGs/EBRs were found for fatigue (n = 4), nausea/vomiting (n = 5), mucositis (n = 4), peripheral neuropathy (n = 3), diarrhoea (n = 2), constipation (n = 2), febrile neutropenia/infection (n = 7), palmar plantar erythrodysesthesia (PPE) (n = 1), and pain (n = 4). SM protocols were provided by >40% of the clinical sites.CONCLUSIONS: A need exists for empirical research on SM for PPE, diarrhoea, and constipation. Research is needed on the efficacy of self-care strategies in patients with BC, CRC, HL, and NHL. In general, consistency exists across CPGs/EBRs and local guidelines on the assessment and management of common CRTs.

KW - adult

KW - aged

KW - aged, 80 and over

KW - antineoplastic agents

KW - breast neoplasms

KW - cell phones

KW - colorectal neoplasms

KW - drug therapy

KW - drug-related side effects

KW - Europe

KW - female

KW - Hodgkin disease

KW - humans

KW - lymphoma

U2 - 10.1016/j.ejon.2016.12.008

DO - 10.1016/j.ejon.2016.12.008

M3 - Article

VL - 26

SP - 63

EP - 82

JO - European Journal of Oncology Nursing

JF - European Journal of Oncology Nursing

SN - 1462-3889

ER -